Trump’s Back, but DC’s Coming for Your Money!

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

RNA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.68%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $28,794,193.75

Avidity Biosciences Insider Trading History Chart

Avidity Biosciences Share Price & Price History

^$51.78

▼ -0.72 (-1.37%)

As of 11/14/2024 03:46 PM ET

Days: 30 | 90 | 365

There is a little known company that is changing warfare

From Reticulate | Ad

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

Avidity Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/21/2024	Arthur A. Levin	Director	Sell	5,000	$46.63	$233,150.00	14,830
10/16/2024	Teresa Mccarthy	Insider	Sell	25,000	$48.52	$1,213,000.00	94,018
10/7/2024	Tamar Thompson	Director	Sell	30,000	$44.98	$1,349,400.00
9/23/2024	Michael F. MacLean	CFO	Sell	11,510	$44.00	$506,440.00	96,355
9/23/2024	Sarah Boyce	CEO	Sell	32,880	$44.00	$1,446,720.00	234,663
9/23/2024	Teresa Mccarthy	Insider	Sell	13,153	$44.00	$578,732.00	69,018
9/19/2024	Arthur A. Levin	Director	Sell	5,000	$45.73	$228,650.00	14,830
8/19/2024	Arthur A. Levin	Director	Sell	5,000	$45.19	$225,950.00	14,830
8/6/2024	Sarah Boyce	CEO	Sell	28,000	$43.35	$1,213,800.00	205,043
7/19/2024	Arthur A. Levin	Director	Sell	5,000	$45.01	$225,050.00	14,830
7/9/2024	Sarah Boyce	CEO	Sell	28,000	$39.93	$1,118,040.00	205,043
6/20/2024	Arthur A. Levin	Director	Sell	5,000	$37.59	$187,950.00	14,830
6/13/2024	Sarah Boyce	CEO	Sell	164,233	$40.08	$6,582,458.64	112,117
6/12/2024	Arthur A. Levin	Director	Sell	40,000	$35.07	$1,402,800.00	213,872
6/12/2024	Michael F. MacLean	CFO	Sell	104,245	$35.72	$3,723,631.40	44,093
6/4/2024	Sarah Boyce	CEO	Sell	28,000	$27.42	$767,760.00	112,117
5/20/2024	Arthur A. Levin	Director	Sell	5,000	$29.90	$149,500.00	14,830
5/14/2024	Michael F. MacLean	CFO	Sell	75,000	$28.28	$2,121,000.00	44,093
5/7/2024	Sarah Boyce	CEO	Sell	28,000	$25.54	$715,120.00	112,117
4/19/2024	Arthur A. Levin	Director	Sell	5,000	$22.82	$114,100.00	14,830
4/3/2024	Arthur A. Levin	Director	Sell	20,000	$27.11	$542,200.00	253,872
3/13/2024	Michael F. MacLean	CFO	Sell	40,000	$24.52	$980,800.00	44,093
3/12/2024	Arthur A. Levin	Director	Sell	27,641	$22.03	$608,931.23	14,830
3/12/2024	Sarah Boyce	CEO	Sell	28,000	$22.63	$633,640.00	112,117
3/8/2024	Sarah Boyce	CEO	Sell	84,000	$21.39	$1,796,760.00	112,117
1/22/2024	Arthur A. Levin	Director	Sell	1,859	$10.13	$18,831.67	17,471
1/22/2024	Michael F. MacLean	CFO	Sell	1,616	$10.13	$16,370.08	16,884
1/22/2024	Sarah Boyce	CEO	Sell	5,092	$10.13	$51,581.96	44,008
1/22/2024	W. Michael Flanagan	Insider	Sell	4,129	$10.13	$41,826.77	35,871
2/14/2023	Arthur A. Levin	Insider	Sell	10,000	$23.66	$236,600.00	19,330
2/3/2023	Sarah Boyce	CEO	Sell	3,221	$24.26	$78,141.46	53,352
2/1/2023	Sarah Boyce	CEO	Sell	900	$24.27	$21,843.00	53,352
1/12/2023	Arthur A. Levin	Insider	Sell	10,000	$22.00	$220,000.00	1,330
8/25/2022	Sarah Boyce	CEO	Sell	14,855	$23.07	$342,704.85
8/15/2022	Arthur A. Levin	Insider	Sell	62,498	$22.12	$1,382,455.76	1,330
8/15/2022	Sarah Boyce	CEO	Sell	100	$22.47	$2,247.00
8/12/2022	Arthur A. Levin	Insider	Sell	14,003	$22.00	$308,066.00	1,330
11/18/2021	Arthur A. Levin	Insider	Sell	25,000	$27.89	$697,250.00

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

SEC Filings (Institutional Ownership Changes) for Avidity Biosciences (NASDAQ:RNA)

Institutional Buying and Selling by Quarter

Avidity Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Verition Fund Management LLC	20,416	$0.94M	0.0%	+175.7%	0.017%
11/14/2024	PEAK6 Investments LLC	7,343	$0.34M	0.0%	+4.9%	0.006%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	348,841	$16.02M	0.0%	-0.4%	0.292%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	21,370	$0.98M	0.0%	-4.1%	0.018%
11/14/2024	MetLife Investment Management LLC	62,364	$2.86M	0.0%	+6.9%	0.052%
11/13/2024	Advantage Alpha Capital Partners LP	10,248	$0.47M	0.1%	N/A	0.009%
11/13/2024	FMR LLC	16,848,776	$773.86M	0.0%	+4.3%	14.122%
11/13/2024	The Manufacturers Life Insurance Company	257,456	$11.83M	0.0%	-5.6%	0.216%
11/12/2024	Algert Global LLC	38,253	$1.76M	0.0%	-10.1%	0.032%
11/12/2024	Nwam LLC	29,662	$1.36M	0.1%	+24.0%	0.025%
11/12/2024	Charles Schwab Investment Management Inc.	990,182	$45.48M	0.0%	+24.8%	0.830%
11/9/2024	Landscape Capital Management L.L.C.	5,767	$0.27M	0.0%	N/A	0.005%
11/9/2024	Intech Investment Management LLC	37,036	$1.70M	0.0%	N/A	0.034%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	217,025	$9.97M	0.0%	+3,836.6%	0.198%
11/7/2024	Quest Partners LLC	2,031	$93K	0.0%	+217.8%	0.002%
11/7/2024	Swiss National Bank	155,600	$7.15M	0.0%	-0.5%	0.142%
11/6/2024	Mutual of America Capital Management LLC	164,997	$7.58M	0.1%	-10.4%	0.150%
11/6/2024	Koa Wealth Management LLC	5,000	$0.23M	0.2%	-37.5%	0.005%
11/5/2024	Victory Capital Management Inc.	33,184	$1.52M	0.0%	+52.1%	0.030%
11/4/2024	Los Angeles Capital Management LLC	14,376	$0.66M	0.0%	N/A	0.013%
11/4/2024	State of New Jersey Common Pension Fund D	44,898	$2.06M	0.0%	N/A	0.041%
11/4/2024	Colonial River Investments LLC	6,165	$0.28M	0.1%	N/A	0.006%
11/4/2024	Axxcess Wealth Management LLC	6,165	$0.28M	0.0%	N/A	0.006%
11/2/2024	Privium Fund Management B.V.	25,600	$1.18M	0.3%	+15.1%	0.023%
11/1/2024	Assetmark Inc.	12,319	$0.57M	0.0%	N/A	0.011%
11/1/2024	Fiera Capital Corp	431,210	$19.81M	0.1%	N/A	0.393%
10/31/2024	Principal Financial Group Inc.	10,040	$0.46M	0.0%	-39.2%	0.009%
10/28/2024	US Bancorp DE	5,244	$0.24M	0.0%	-91.0%	0.005%
10/25/2024	China Universal Asset Management Co. Ltd.	22,526	$1.04M	0.1%	+100.5%	0.021%
10/25/2024	abrdn plc	24,836	$1.14M	0.0%	-30.3%	0.023%
10/24/2024	Nisa Investment Advisors LLC	3,465	$0.16M	0.0%	-21.2%	0.003%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	4,236	$0.18M	0.0%	+48.4%	0.004%
10/23/2024	Values First Advisors Inc.	688	$32K	0.0%	N/A	0.001%
10/23/2024	Hennion & Walsh Asset Management Inc.	78,238	$3.59M	0.2%	-1.2%	0.071%
10/22/2024	International Assets Investment Management LLC	36,744	$16.88M	0.0%	N/A	0.033%
10/21/2024	Precision Wealth Strategies LLC	5,468	$0.25M	0.2%	N/A	0.006%
10/19/2024	Allspring Global Investments Holdings LLC	657	$30K	0.0%	N/A	0.001%
10/18/2024	Raymond James & Associates	156,763	$7.20M	0.0%	+2.0%	0.143%
10/18/2024	Moss Adams Wealth Advisors LLC	22,496	$1.03M	0.1%	-41.1%	0.020%
10/17/2024	Aaron Wealth Advisors LLC	7,598	$0.35M	0.0%	N/A	0.008%
10/16/2024	Teamwork Financial Advisors LLC	7,000	$0.32M	0.0%	N/A	0.007%
10/11/2024	Creative Planning	23,806	$1.09M	0.0%	+76.5%	0.022%
10/5/2024	Mirador Capital Partners LP	30,498	$1.40M	0.3%	-25.5%	0.032%
10/3/2024	SG Americas Securities LLC	12,675	$0.58M	0.0%	-86.8%	0.012%
8/16/2024	Quarry LP	2,000	$82K	0.0%	+566.7%	0.002%
8/16/2024	Creative Planning	13,487	$0.55M	0.0%	+45.1%	0.014%
8/16/2024	Algert Global LLC	42,563	$1.74M	0.1%	+32.5%	0.045%
8/15/2024	Alethea Capital Management LLC	503,504	$20.57M	15.6%	-33.8%	0.526%
8/15/2024	The Manufacturers Life Insurance Company	272,762	$11.14M	0.0%	+18.5%	0.285%
8/15/2024	Millennium Management LLC	125,375	$5.12M	0.0%	-25.6%	0.131%
8/15/2024	D. E. Shaw & Co. Inc.	739,039	$30.19M	0.0%	+2,263.7%	0.773%
8/15/2024	Darwin Global Management Ltd.	200,000	$8.11M	0.9%	N/A	0.209%
8/15/2024	AQR Capital Management LLC	12,042	$0.49M	0.0%	N/A	0.013%
8/14/2024	Squarepoint Ops LLC	115,508	$4.72M	0.0%	+81.1%	0.121%
8/14/2024	Fred Alger Management LLC	15,625	$0.64M	0.0%	N/A	0.016%
8/14/2024	Marshall Wace LLP	111,770	$4.57M	0.0%	+9.7%	0.117%
8/14/2024	Farallon Capital Management LLC	5,000	$0.20M	0.0%	-99.2%	0.005%
8/14/2024	Xponance Inc.	6,421	$0.26M	0.0%	N/A	0.007%
8/14/2024	Avoro Capital Advisors LLC	6,505,000	$265.73M	3.5%	+11.7%	6.802%
8/14/2024	ProShare Advisors LLC	17,156	$0.70M	0.0%	-9.1%	0.018%
8/14/2024	Profund Advisors LLC	21,426	$0.88M	0.0%	-33.2%	0.022%
8/13/2024	Sei Investments Co.	43,721	$1.79M	0.0%	+19.3%	0.046%
8/13/2024	Public Employees Retirement Association of Colorado	7,806	$0.32M	0.0%	N/A	0.008%
8/12/2024	Hsbc Holdings PLC	13,725	$0.56M	0.0%	-9.1%	0.014%
8/12/2024	Amalgamated Bank	3,497	$0.14M	0.0%	+39.0%	0.004%
8/12/2024	E Fund Management Co. Ltd.	6,640	$0.27M	0.0%	-30.1%	0.007%
8/10/2024	Mutual of America Capital Management LLC	184,249	$7.53M	0.1%	+28.5%	0.193%
8/10/2024	Sofinnova Investments Inc.	21,425	$0.88M	0.0%	N/A	0.022%
8/9/2024	Renaissance Technologies LLC	377,400	$15.42M	0.0%	N/A	0.395%
8/9/2024	Dimensional Fund Advisors LP	693,066	$28.31M	0.0%	-31.4%	0.725%
8/8/2024	American Century Companies Inc.	164,631	$6.73M	0.0%	+18.5%	0.172%
8/7/2024	Daiwa Securities Group Inc.	2,092	$85K	0.0%	-79.0%	0.002%
8/7/2024	Dorsey & Whitney Trust CO LLC	6,990	$0.29M	0.0%	N/A	0.007%
8/7/2024	Cowen AND Company LLC	5,129,103	$209.52M	5.8%	-8.9%	5.363%
8/6/2024	Quest Partners LLC	639	$26K	0.0%	-51.7%	0.001%
8/5/2024	Arizona State Retirement System	19,965	$0.82M	0.0%	+2.1%	0.021%
8/5/2024	Victory Capital Management Inc.	21,817	$0.89M	0.0%	+134.1%	0.023%
8/3/2024	9258 Wealth Management LLC	9,657	$0.39M	0.1%	N/A	0.010%
8/3/2024	TD Asset Management Inc	513,338	$20.97M	0.0%	+140.7%	0.537%
8/1/2024	Rhumbline Advisers	141,481	$5.78M	0.0%	+19.0%	0.148%
8/1/2024	Privium Fund Management B.V.	22,242	$0.86M	0.2%	+176.6%	0.023%
7/31/2024	nVerses Capital LLC	3,400	$0.14M	0.1%	+25.9%	0.004%
7/29/2024	Principal Financial Group Inc.	16,524	$0.68M	0.0%	-6.3%	0.017%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	22,277	$0.91M	0.0%	+48.3%	0.023%
7/26/2024	Bank of New York Mellon Corp	363,953	$14.87M	0.0%	+46.6%	0.381%
7/26/2024	EFG Asset Management North America Corp.	29,992	$1.23M	0.2%	N/A	0.031%
7/23/2024	Moss Adams Wealth Advisors LLC	38,213	$1.56M	0.2%	N/A	0.040%
7/20/2024	China Universal Asset Management Co. Ltd.	11,235	$0.46M	0.1%	-26.6%	0.012%
7/20/2024	Nisa Investment Advisors LLC	4,399	$0.18M	0.0%	+32.4%	0.005%
7/20/2024	Hennion & Walsh Asset Management Inc.	79,213	$3.24M	0.2%	+8.6%	0.083%
7/19/2024	Raymond James & Associates	153,632	$6.28M	0.0%	-48.0%	0.161%
7/18/2024	Assenagon Asset Management S.A.	48,969	$2M	0.0%	N/A	0.051%
7/13/2024	Mirador Capital Partners LP	40,913	$1.67M	0.3%	-13.1%	0.043%
7/12/2024	SG Americas Securities LLC	96,279	$3.93M	0.0%	+2,083.7%	0.101%
5/28/2024	Teachers Retirement System of The State of Kentucky	20,867	$0.53M	0.0%	N/A	0.022%
5/24/2024	Farallon Capital Management LLC	606,061	$15.47M	0.1%	N/A	0.634%
5/17/2024	RA Capital Management L.P.	3,282,180	$83.76M	1.1%	+33.7%	3.432%
5/17/2024	Alethea Capital Management LLC	760,697	$19.41M	15.8%	-11.0%	0.795%
5/16/2024	California State Teachers Retirement System	71,574	$1.83M	0.0%	+10.2%	0.075%
5/16/2024	Janus Henderson Group PLC	1,242,833	$31.70M	0.0%	+4,661.3%	1.299%

Data available starting January 2016

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $51.78

$51.56

$54.12

50 Day Range

MA: $45.04

$40.46

$52.50

52 Week Range

Now: $51.78

$5.68

$56.00

Volume

879,958 shs

Average Volume

1,313,293 shs

Market Capitalization

$6.18 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of Avidity Biosciences?: Avidity Biosciences' top insider investors include:
Arthur A Levin (Director)
Sarah Boyce (CEO)
Michael F Maclean (CFO)
Teresa Mccarthy (Insider)
W Michael Flanagan (Insider)
Arthur A Levin (Insider)
Tamar Thompson (Director)
Learn More about top insider investors at Avidity Biosciences.
Who are the major institutional investors of Avidity Biosciences?: Avidity Biosciences' top institutional investors include:
FMR LLC — 14.12%
Charles Schwab Investment Management Inc. — 0.83%
Fiera Capital Corp — 0.39%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.29%
The Manufacturers Life Insurance Company — 0.22%
Connor Clark & Lunn Investment Management Ltd. — 0.20%
Learn More about top institutional investors of Avidity Biosciences stock.
Which major investors are selling Avidity Biosciences stock?: During the previous quarter, RNA stock was sold by these institutional investors:
SG Americas Securities LLC
US Bancorp DE
Mutual of America Capital Management LLC
Moss Adams Wealth Advisors LLC
The Manufacturers Life Insurance Company
abrdn plc
Mirador Capital Partners LP
Principal Financial Group Inc.
Within the previous year, company insiders that have sold Avidity Biosciences company stock include:
Arthur A Levin (Director)
Sarah Boyce (CEO)
Michael F Maclean (CFO)
Teresa Mccarthy (Insider)
W Michael Flanagan (Insider)
Arthur A Levin (Insider)
Learn More investors selling Avidity Biosciences stock.
Which major investors are buying Avidity Biosciences stock?: Within the previous quarter, RNA stock was purchased by institutional investors including:
FMR LLC
Fiera Capital Corp
Connor Clark & Lunn Investment Management Ltd.
Charles Schwab Investment Management Inc.
State of New Jersey Common Pension Fund D
Intech Investment Management LLC
International Assets Investment Management LLC
Citigroup Inc.